Is Rezdiffra Covered by Insurance? What Patients Need to Know
Introduction For patients living with MASH (metabolic dysfunction-associated steatohepatitis), the approval of Rezdiffra (resmetirom) marked a turning point. As the first FDA-approved treatment specifically designed for adults with noncirrhotic MASH with moderate to advanced liver fibrosis, Rezdiffra brought real hope to a population that had very few options for so long. But hope doesn’t always…